April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM). Investors who purchased Select Medical prior to March 2, 2026, and continue to hold to the present are encouraged to obtain additional information and assist the investigation…. read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating Forian Inc. (“Forian”) (NASDAQ: FORA). Investors who purchased Forian prior to April 2, 2026, and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FORA. Forian… read more
April 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alstom S.A. (“Alstom” or “the Company”) (OTCMKTS: ALSMY; AOMFF). Investors who purchased Alstom securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alstom has violated… read more
April 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of F5, Inc. (“F5” or “the Company”) (NASDAQ: FFIV). Investors who purchased F5 securities prior to October 28, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
April 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RH (“RH” or “the Company”) (NYSE: RH). Investors who purchased RH securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether RH has violated federal securities… read more
April 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 19, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CarMax, Inc. (“CarMax” or “the Company”) (NYSE: KMX). Investors who purchased CarMax securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CarMax has violated federal… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ORIC Pharmaceuticals, Inc. (“Oric” or “the Company”) (NASDAQ: ORIC). Investors who purchased Oric securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Oric has violated… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lucid Group, Inc. (“Lucid” or “the Company”) (NASDAQ: LCID). Investors who purchased Lucid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lucid has violated… read more
April 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lucid Group, Inc. (“Lucid” or “the Company”) (NASDAQ: LCID). Investors who purchased Lucid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lucid has violated… read more
April 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Picard Medical, Inc. (“Picard Medical” or “the Company”) (NYSE: PMI). Investors who purchased Picard Medical securities prior to September 2, 2025, and continue to hold to the present, are encouraged to… read more
April 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Replimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL). Investors who purchased Replimune securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Replimune has violated… read more
April 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sezzle Inc. (“Sezzle” or “the Company”) (NASDAQ: SEZL). Investors who purchased Sezzle securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sezzle has violated federal… read more
April 14, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between dMY Technology Group, Inc. IV (“dMY IV”) (NYSE: DMYQ) and Planet Labs PBC (“Planet Labs”) (NYSE: PL). The investigation focuses on whether dMY IV’s board of directors breached its fiduciary duties and failed to provide… read more
April 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AIRO Group Holdings, Inc. (“Airo” or “the Company”) (NASDAQ: AIRO). Investors who purchased Airo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Airo has… read more
April 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of J.Jill, Inc. (“J.Jill” or “the Company”) (NYSE: JILL). Investors who purchased J.Jill securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether J.Jill has violated federal… read more
April 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Simply Good Foods Company (“Simply Good Foods” or “the Company”) (NASDAQ: SMPL). Investors who purchased Simply Good Foods securities are encouraged to obtain additional information and assist the investigation. The… read more
April 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fair Isaac Corporation (“Fair Isaac” or “the Company”) (NYSE: FICO). Investors who purchased Fair Isaac securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fair… read more
April 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of G-III Apparel Group, Ltd. (“G-III” or “the Company”) (NASDAQ: GIII). Investors who purchased G-III securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether G-III has… read more
April 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of G-III Apparel Group, Ltd. (“G-III” or “the Company”) (NASDAQ: GIII). Investors who purchased G-III securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether G-III has… read more
April 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BitGo Holdings, Inc. (“BitGo” or “the Company”) (NYSE: BTGO). Investors who purchased BitGo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BitGo has violated… read more
April 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHT). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHT). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHT). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHT). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Phreesia has violated federal… read more
April 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Theravance Biopharma, Inc. (“Theravance” or “the Company”) (NASDAQ: TBPH). Investors who purchased Theravance securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Theravance has violated… read more
April 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Theravance Biopharma, Inc. (“Theravance” or “the Company”) (NASDAQ: TBPH). Investors who purchased Theravance securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Theravance has violated… read more
March 31, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walker & Dunlop, Inc. (“Walker & Dunlop” or “the Company”) (NYSE: WD). Investors who purchased Walker & Dunlop securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
March 31, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walker & Dunlop, Inc. (“Walker & Dunlop” or “the Company”) (NYSE: WD). Investors who purchased Walker & Dunlop securities are encouraged to obtain additional information and assist the investigation. The investigation… read more